Physician profile
Prateek Srinet
NPI 1144541772
$7,899.35
in general payments reported to CMS, 2019-2025
23 companies · $805 in 2025
The $805 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,888 · 2020: $65.17 · 2021: $986 · 2022: $677 · 2023: $1,931 · 2024: $547 · 2025: $805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,202 · Travel and Lodging: $869 · Education: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,202.02 |
| Travel and Lodging | $868.88 |
| Education | $211.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $2,991.73 | 2019-2022 | |
| Aerin Medical INC. | $1,231.36 | 2022-2025 | |
| Acclarent, INC | $960.06 | 2020-2024 | Relieva Spinplus, Acclarent Aera, Acclarent Navwire |
| Optinose US, INC. | $588.45 | 2021-2025 | |
| Genzyme Corporation | $469.40 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $301.99 | 2021-2025 | Dupixent |
| Integra Lifesciences Corporation | $250.63 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Glaxosmithkline, LLC. | $238.29 | 2021-2025 | Nucala |
| Sanofi-Aventis U.S. LLC | $152.98 | 2023-2024 | |
| Stryker Corporation | $142.77 | 2020-2025 | Scopis Ent, Clarifix, Xpress Loprofile |
| Medical Device Business Services, INC. | $139.78 | 2021 | |
| Resmed Corp | $77.90 | 2023-2025 | |
| Smith+Nephew, INC. | $74.78 | 2020-2025 | Tula, Sinu-Foam |
| Karl Storz Endoscopy-America | $55.67 | 2019 | |
| Axsome Therapeutics, INC. | $53.20 | 2023-2025 | Sunosi |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $43.70 | 2023 | Propel, Stealthstation S8 Platform |
| Jazz Pharmaceuticals INC. | $23.53 | 2023 | |
| Idorsia Pharmaceuticals US INC | $20.71 | 2023 | Quviviq |
| Avadel Cns Pharmaceuticals, LLC | $19.46 | 2024 | Lumryz |
| Paratek Pharmaceuticals, INC. | $16.56 | 2025 | Xhance, Nuzyra |
| Hikma Pharmaceuticals USA | $16.10 | 2025 | Ryaltris |
| Inspire Medical Systems, INC. | $15.31 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $14.99 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prateek Srinet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.